New Jersey Administrative Code › Title 13 - LAW AND PUBLIC SAFETY › Chapter 35 - BOARD OF MEDICAL EXAMINERS › Subchapter 13 - PERFUSIONISTS ADVISORY COMMITTEE › Section 13:35-13.2 - Definitions

Current through Register Vol. 56, No. 14, July 15, 2024
The following words and terms, when used in this subchapter, shall have the following meanings, unless the context clearly indicates otherwise:
"Act" means the Perfusionist Licensing Act, N.J.S.A. 45:9-37.9 4 et seq.
"Address of record" means an address designated by a licensee which is part of the public record and which may be disclosed upon request made to the Committee. "Address of record" may be a licensee's home, business, mailing address, or a post office box.
"Board" means the State Board of Medical Examiners.
"Committee" means the Perfusionists Advisory Committee established pursuant to section 4 of P.L. 1999, c. 126 (N.J.S.A. 45:9-37.9 7 et seq.)
"Licensee" means an individual holding a license issued by the Perfusionist Advisory Committee under the State Board of Medical Examiners.
"Extracorporeal circulation" means the diversion of a patient's blood through a heart-lung machine or a similar device that assumes the functions of the patient's heart, lungs, kidney, liver or other organs.
"Perfusionist" means a person who is licensed to practice perfusion pursuant to the provisions of P.L. 1999, c. 126 (N.J.S.A. 45:9-37.9 4 et seq.).
"Perfusion" means the functions necessary for the support, treatment, measurement or supplementation of the cardiovascular, circulatory or respiratory system or other organs, or a combination of those activities, and to ensure the safe management of physiologic functions by monitoring and analyzing the parameters of the systems under an order and under the supervision of a licensed physician, including:
1. The use of extracorporeal circulation, long-term cardiopulmonary support techniques including extracorporeal carbon-dioxide removal and extracorporeal membrane oxygenation, and associated therapeutic and diagnostic technologies;
2. Counterpulsation, ventricular assistance, autotransfusion, blood conservation techniques, myocardial and organ preservation, extracorporeal life support and isolated limb perfusion;
3. The use of techniques involving blood management, advanced life support and other related functions;
4. In the performance of the activities described above, the administration of:
i. Pharmacological and therapeutic agents;
ii. Blood products or anesthetic agents through the extracorporeal circuit or through an intravenous line as ordered by a physician;
5. In the performance of the activities described above, the performance and use of:
i. Anticoagulation monitoring and analysis;
ii. Physiologic monitoring and analysis;
iii. Blood gas and chemistry monitoring and analysis;
iv. Hematologic monitoring and analysis;
v. Hypothermia;
vi. Hyperthermia;
vii. Hemoconcentration and hemodilution;
viii. Modified extracorporeal circulatory hemodialysis; and
6. The observation of signs and symptoms related to perfusion services, the determination of whether the signs and symptoms exhibit abnormal characteristics and the implementation of appropriate reporting, perfusion protocols, or changes in or the initiation of emergency procedures.